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Abstract
Background. Polychlorinated biphenyls (PCBs) have been found to
be associated with diabetes in some, but not all, studies performed so
far. The aim of this study was to assess the association between PCB
serum levels and glycaemia and diabetes in people living in Brescia, a
highly industrialised PCB-polluted town in Northern Italy. 
Design and Methods. 527 subjects were enrolled in a cross-sectional
population-based study: they were interviewed face-to-face in 2003
and also provided a blood sample under fasting conditions. The con-
centration of 24 PCB congeners was determined using gas-chromatog-
raphy (GC/MS). Subsequently, all subjects were included in a follow-up
(cohort) study. According to the Local Health Authority health-care
database, subjects were considered to be diabetic if they had diabetes
at interview time (prevalent cases) or during a 7-year follow-up (inci-
dent cases).
Results. A total of 53 subjects (10.0%) were diabetics: 28 had dia-
betes at enrolment and other 25 developed the disease subsequently.
Diabetes frequency increased according to the serum concentrations
of total PCBs and single PCB congeners, but no association was found
when estimates were adjusted for education, body mass index, age and
gender by logistic regression analysis. Accordingly, glycaemia
increased with PCB serum levels, but no association was observed
when multiple regression analysis, including confounding factors, was
performed.
Conclusions. This study does not support the hypothesis that PCB
environmental exposure is strictly associated with diabetes or gly-
caemia.
Introduction 
Polychlorinated biphenyls (PCBs) are defined as persistent organic
pollutants (POPs) and toxic chemicals, which persist in the environ-
ment for long periods of time and biomagnify as they move up through
the food chain.1 PCBs are mixtures of up to 209 different compounds
(congeners), depending on the number and position of chlorine atoms
attached to the biphenyl molecule. PCBs were widely used in the past,
especially in electrical, heat transfer and hydraulic equipment, and in
plasticizers, paints, plastic and rubber products, but their production
was stopped in many countries in response to the negative impact that
these compounds had on environmental and human health.1 PCBs,
especially the 12 PCB congeners that have dioxin-like activity, have
been linked to several and adverse health effects on human and ani-
mals, such as: cancer,1 damage to the nervous system, reproductive
disorders and disruption of the endocrine and immune systems.2
Recently, it has been suggested that POPs stored in body fat may con-
tribute to the onset of diabetes or insulin resistance, in addition to
obesity, unhealthy diet and physical inactivity.3 PCBs, especially PCB
153, and PCDD/Fs were found to be associated with diabetes in various
studies carried out in the 2000s.4-9 However, no clear pathogenic
mechanism has been identified and the association of dioxins and
PCBs with diabetes hasn’t been found in other studies.10-14 So, up to
date, no conclusion can be drawn at present and more research is
required.3 In Brescia, a highly industrialised town in Northern Italy
with about 200,000 inhabitants, a chemical factory produced PCBs
from 1930 to 1984, and these compounds polluted the soil of nearby
agricultural areas via irrigation channels, entered the food chain and
thus accumulated in human beings.15,16 Other POPs, including poly-
chlorinated dibenzo-para-dioxins (PCDDs) and polychlorinated diben-
zofurans (PCDFs), have also been found in the environment, animal-
derived food (meat, eggs, milk and dairy products) and human sera,
with a high correlation with PCB levels.17,18 The aim of this study was
to assess the association between PCB serum levels and glycaemia and
diabetes in people living in this town.
Design and methodsStudy population
In the first phase of this cross-sectional and cohort study (2003-
Significance for public health
The aim of this research was to assess the association between polychlori-
nated biphenyls (PCBs)  serum levels, glycaemia and diabetes, with a cross-
sectional population-based study and a subsequent cohort study with a 7 year
follow-up. An association between diabetes and concentration of PCBs
serum levels was found by crude analysis, but it disappeared when adjusting
for education, body mass index, age and gender as confounders.
The results of this study, which was carried on people living in a highly PCB-
polluted area, provide information on the possible intervention of Public
Health to contrast onset of diseases related to PCB exposure and put forward
some useful suggestions for an environmental policy. 
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2004), we performed a survey on a random sample of adult residents in
Brescia (Italy). Here, there was an important factory which produced
organochlorine compounds, including PCBs, from the 1930s to 1984.
PCBs were released into drainage water, which was discharged in irri-
gation channels and then accumulated in the soil of a nearby agricul-
tural area, entering the food chain. Therefore, PCB polluted food, main-
ly animal products (chicken, eggs, milk and cheese), was consumed by
several individuals living in the town.15,16 Four different areas and their
residents were identified according to soil PCB concentrations. The
stratified sampling design was based on separate frames for subjects
resident in each of these 4 areas, separately for sex and divided into six
age groups, from 20 to 79 years. An invitation letter was sent to 1200
subjects: 308 of them did not respond the letter and could not be found
by telephone. Among the 892 contacted people, 579 (64.8%) agreed to
participate and gave a blood sample for laboratory determination; 527
of them were face-to-face interviewed by a trained nurse using a struc-
tured questionnaire, including questions on demographic variables,
weight and height, residential and occupational history, smoking habit,
alcohol intake, and presence of past and current diseases.  
Body mass index (BMI) was computed by dividing the weight in kilo-
grams by the square of the height in meters. We indentified 3 cate-
gories of BMI according to the cut-off points proposed by the WHO:19
normal weight (BMI<25 kg/m2), overweight (25≤BMI<30 kg/m2) and
obese (BMI≥30 kg/m2).  
Subjects were questioned about the presence of diabetes and current
use of insulin or oral hypoglycaemic agents. They were considered to
have diabetes (prevalent cases) if they reported a history of type I or
type II diabetes and/or if they were currently using insulin or oral hypo-
glycaemic agents. In Italy, citizens are registered in the General
Registry Health database of the National Health Service (NHS) with a
unique identification code. All subjects affected by chronic diseases
can benefit free of charge analyses, drugs, physicians’ visits, and other
services provided by the NHS. All these data are made available to each
Local Health Authority. Therefore, in order to detect the occurrence of
diabetes, we merged our database with Brescia Local Health Authority
(LHA) health-care one, including both administrative and health data
of all the subjects living in the area. A complete description and validi-
ty considerations on this database are given elsewhere.20 In the second
phase of the study, all subjects enrolled in the survey were included in
a cohort study.  During a 7-year follow-up, from 1st January 2004 to 31st
December 2011, all the new cases of diabetes, which occurred in the
cohort, were retrieved using the LHA database (incident cases).
The Ethics Committee of the LHA approved the project and each par-
ticipant provided informed consent. Blood sampling and storage
A 20-mL blood sample was collected from each subject. Fasting plas-
ma glucose was determined using the glucose-oxidase method. Serum
lipid profile, including total cholesterol and triglycerides, was evaluat-
ed using enzymatic methods.
The serum was separated by centrifugation at 3500 rpm (5 min) and
stored at –20°C until the chemical analyses were performed. Polychlorinated biphenyls analyses
We determined the serum concentration of 24 PCB congeners - 28,
31, 52, 77, 81, 101, 105, 114, 118, 123, 126, 128, 138, 153, 156, 157, 167,
169, 170, 180, 189, 194, 206 and 209 - according to Ballschmiter and
Zell’s study.21
PCBs were measured using a Hewlett-Packard 6890N gas chromato-
graph coupled with an MSD HP 5973. Analytical procedure, limit of
quantification and method accuracy assessment are reported else-
where.15 PCB analysis was performed at the Laboratory of Occupational
Hygiene and Toxicology, Brescia University, Italy.
For the 12 dioxin-like congeners (DL-PCBs) 77, 81, 126, 169, 105,
114, 118, 123, 156, 157, 167 and 189, the total toxic equivalency (TEQ)
was computed using toxic equivalency factor (TEF) defined by Van den
Berg’s study.22 A minimum concentration of half the quantification
limit (0.05 ng/mL) was attributed to subjects with no detection for PCB
congeners that were detectable in at least 30% of subjects. A null value
was attributed to congeners with detectable values in less than 30% of
subjects, according to common suggestions.15 Total PCB concentration
was calculated by summing up values of PCB congeners. 
Since PCBs are transported in the lipidic fraction of the blood, their
concentration depends on the amount of serum lipids. The ratio of PCB
concentrations to total lipid levels was therefore computed (lipid-
adjusted PCB concentration) and expressed as ng/g lipid, the standard
practice in studies investigating PCB serum levels. We calculated the
total lipid concentration from cholesterol and triglyceride levels, using
the formula suggested by Philips’ work:23 total serum lipids (g/dL) =
2.27 ¥ serum cholesterol (g/dL) + triglycerides (g/dL) + 0.623.Statistical analysis 
The distribution of total PCB serum levels was examined using com-
mon statistical techniques for exploratory analysis. Due to the asym-
metrical, non-normal distribution of total PCBs and of each PCB con-
gener, the mean, median, range and 95th centile of the distributions are
shown.  PCB congeners were classified on the basis of their different
functional groups, according to the classification proposed by various
authors as:24-26 i) congeners with immunotoxic activities (PCB 138,
153 and 180); ii) low-chlorinated PCBs with pseudo-oestrogen activity
(PCB 28, 52 and 153); iii) high-chlorinated PCBs with anti-oestrogenic
activities (PCB 170, 180 and 194); iv) PCBs that can induce phenobar-
bital (PCB 101, 153, 180 and 194). The proportions of subjects with dia-
betes (prevalent and incident cases separately and all together)  were
compared according to the total PCB distribution tertiles, specific PCB
congeners and PCB functional groups and TEQ DL- PCBs. Logistic
regression analysis was also performed to evaluate the association
between diabetes,  PCB serum levels (distribution tertiles), adjusting
for education, age, gender and BMI, and the corresponding odds ratios
(ORs) were computed. Glycaemia levels according to the total PCB dis-
tribution tertiles, PCB 153 and PCB functional groups were compared
using the analysis of variance on log-transformed data. Multiple regres-
sion of log-glycaemia as the dependent variable was also performed,
with PCBs levels, education, gender, age and BMI as independent vari-
ables. All the statistical tests were two-sided with a 0.05 P-value to
refute the null hypothesis. Statistical analysis was performed using
STATA software for personal computer (Stata Statistical Software
release 10, 2003; Stata Corporation, College Station, Texas, USA).
Results
A total of 527 subjects were enrolled. Table 1 shows the distribution
of participants according to education, age, gender and BMI: 48.5% of
subjects were males, mean age was 50.6 years, mean BMI was 24.8
kg/m2, and 56% had less than 8 years of schooling. According to BMI
categories, 291 subjects (55.2%) had normal weight, 163 (30.9%) were
overweight and 73 (13.9%) were obese.
Table 2 shows descriptive statistics of the lipid-adjusted serum levels
of total PCBs, PCB congeners and PCB functional groups. The median
serum concentration of total PCBs was 713.7 ng/g lipid and the range
was 55.4-34377.8 ng/g lipid. PCB 153 and PCB 180 contributed most to
total PCB level: the medians of PCB 153 and 180 were 207.9 (range 4.7-
5618.1) ng/g lipid and 233.9 (range 9.1-11296.4) ng/g lipid, respective-
ly. The PCB congeners set out in the table were over the detection limit
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in all subjects. No data are shown for congeners that were undetectable
in all or almost all samples, i.e. PCB 28 (0% of detectable values), PCB
52 (0%), PCB 101 (1.5%) and PCB 126 (0%). We found no differences
between males and females in serum levels of total and single PCB con-
geners. In the cross sectional study, 28 subjects were found to have dia-
betes (prevalence: 5.3%; 95% CI: 3.3-7.2). All the 527 subjects, who were
already included in the cross-sectional study, were also enrolled in the
cohort study. After 7 years of follow-up, 32 (6.0%) of them were dead
and 9 (1.7%) were not found in the LHA database (lost at follow-up).
Other 25 subjects of the cohort developed diabetes (incident cases)
among those who did not have the disease at the enrolment (cumula-
tive incidence: 5.0%; 95% CI: 3.1-6.9). Overall, 53 (10.0%) subjects were
found to have diabetes according to the initial interview (n=28) or dur-
ing the follow-up (n=25). For all the subjects, who reported diabetes at
the interview, the presence of that disease was confirmed via the LHA
database.
Prevalent and incident cases of diabetes were considered all togeth-
er for the comparison with non-diabetics subjects (controls). The dia-
betes cases were older than controls, with a median age of 62.4 and
51.3 years, respectively (P<0.001). PCBs concentration increased with
the age in both diabetes cases and subjects without diabetes (P<0.01):
in the whole sample, PCB serum levels were higher in  subjects aged
62.4 years and older (median: 1229.5 ng/g lipid) compared with
younger subjects (median: 554.8 ng/g lipid) (P<0.001). 
The median serum levels of total PCBs, according to the BMI, were,
with respect to normal weight subjects (628.8 ng/g lipid), higher in
overweight subjects (867.2 ng/g lipid, P<0.001), but not significantly
different in obese subjects (684.6 ng/g lipid; P=0.1). Diabetes preva-
lence increased with age and BMI, with a maximum of 20.5% among
subjects aged 60 years and over, and 29.4% among the 68 obese sub-
jects (BMI of 30 and over), more than six times the proportion in nor-
mal-weight individuals (29.4% vs 4.1%). Only one (5%) of those obese
subjects had total PCB levels higher than the median of the distribu-
tion. When comparing prevalent and incident diabetes cases, we found
no differences in serum levels of total PCBs between them: mean
serum levels of PCBs were 1360.7 and 1166.9 ng/g lipid in prevalent and
incident cases, respectively (P=0.18). 
The odds ratios for diabetes according to tertiles of serum total PCB
concentration, adjusted for education, BMI, age and gender, were:  for
prevalence of diabetes: OR=0.5 (0.1-2.2) for both 2nd and 3rd vs 1st ter-
tiles; for cumulative incidence of diabetes: OR=2.3 (0.6-9.6) for 2nd and
0.9 (0.2-5.0) for 3rd vs 1st tertiles, respectively. There was no associa-
tion between diabetes and total PCBs, PCB 153, 4 PCB functional
groups and TEQ DL-PCBs concentration both in prevalent cases and in
incident cases. According to those findings, we decided to analyse the
association between diabetes and PCBs concentration combining all
diabetes cases together to increase the power of the study.
Table 3 shows the overall cases of diabetes (prevalent and incident
cases together) and the odds ratios (ORs) for diabetes according to dis-
tribution tertiles for the serum concentration of lipid-adjusted total
PCBs, PCB 153, PCB functional groups and TEQ DL-PCBs. The propor-
tion of diabetes cases increased with the concentration of total PCBs,
single PCB congeners and PCB functional group. However, diabetes did
not show a statistically significant association with PCB when adjust-
ing for education, BMI, age and gender by logistic regression analysis.
The differences between the crude and adjusted OR estimates were
entirely due to age, which therefore was a confounder of the associa-
tion whereas gender, BMI and education were not. Diabetes was asso-
ciated with obesity (BMI≥30), but not overweight (24.9≥BMI≤30), the
OR for obesity being 7.2 (3.4-16.2), and none of these associations was
confounded or modified by PCB serum levels. No differences were
found when restricting the analysis to the 25 incident diabetes cases
only. No association was found between diabetes and serum concentra-
tion of lipid-adjusted PCBs according to concentration tertiles when
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Figure 1. Distribution of glycaemia values according to log-trans-
formed, lipid-adjusted, total polychlorinated biphenyls serum
levels.
Table 1. Age, gender, body mass index and education of subjects
enrolled in the study.
Males Females Total
N. (%) N. (%) N. (%)
All subjects 256 (48.5) 271 (51.5) 527 (100)
Age (years)
20-39 72 (28.2) 81 (29.9) 153 (29.0)
40-59 89 (34.7) 105 (38.7) 194 (36.8) 
60-79 95 (37.1) 85 (31.4) 180 (34.2)
Mean ± SD age (years) 51.7±16.4 50.3±16.0 50.6±6.2
Mean ± SD BMI (kg/m2) 25.3±3.8 24.3±5.0 24.8±4.5
Education (years)
≤5 59 (23.0) 79 (29.2) 138 (26.2)
6-8 70 (27.4) 79 (29.2) 149 (28.3)
>8 127 (49.6) 113 (41.6) 240 (45.5)
SD, standard deviation; BMI, body mass index.
Table 2. Lipid-adjusted polychlorinated biphenyls (PCB) con-
gener, total PCB, PCB functional group and total toxic equiva-
lency dioxin like PCBs serum levels (ng/g lipid).
PCB congener Mean Median 95th Range
(ng/g lipid) percentile
Total PCBs 1309.3 713.7 3520.9 55.4-34377.8
138 187.5 118.2 481.9 4.7-4192.9
153 331.6 207.9 883.3 4.7-5618.1
170 113.0 64.4 332.3 5.6-2737.6
180 423.7 233.9 1032.5 9.1-11296.4
194 114.2 41.0 352.4 4.1-4216.3
Immunotoxic PCBs 942.9 565.7 2459.9 37.4-18732.4
(PCB138+153+180)
Pseudo-oestrogen PCBs 331.6 207.9 883.3 4.7-5618.1
(PCB28+52+153)
High chlorinated 651.0 342.4 1668.5 27.4-18122.5
anti-oestrogenic PCBs 
(PCB170+180+194)
Phenobarbital inducer 869.8 499.9 2233.8 37.4-20402.1
PCBs (PCB101+153
+180+194)
TEQ DL-PCBs 0.13 0.05 0.43 0.03-4.3
PBC, polychlorinated biphenyls congener; TEQ, total toxic equivalency.
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analysing subjects with normal weight, overweight and obesity sepa-
rately. No difference was found in the OR estimates for PCB tertiles
when dichotomizing subjects in those under and over 62.4 years of age
(median age of diabetics): the ORs for the 3rd vs 1st tertile were 0.8
(95% CI:0.2-3.8) and 0.3 (95% CI:0.1-1.5), respectively. A high disper-
sion of glycaemia according to PCB lipid-adjusted values was observed
(Figure 1), with a weak linear correlation (Spearman’s r=0.2).
However, multiple regression analysis, with logarithm of glycaemia as
the dependent variable, showed no association with log-transformed
total PCB concentration when including age, BMI, education and gen-
der. Table 4 shows the geometric mean of glycaemia according to ter-
tiles of lipid-adjusted total PCBs, PCB 153 and four functional groups in
474 subjects without diabetes. Statistically significant associations
between logarithm of glycaemia and tertiles of PCB lipid-adjusted lev-
els were found for total PCBs, PCB153 and four PCB functional groups
using one-way ANOVA on log-transformed glycaemia data, which were
not confirmed when adjusting for education, BMI, age and gender by
multi-way ANOVA. The associations between PCB serum levels and dia-
betes and glycaemia were also analysed in men and women separately,
providing similar results to those observed in total subjects.
Discussion
In spite of a high exposure of the study population to PCBs and pos-
sibly PCDD/Fs for about half a century, we found no relationship
between total PCB serum levels and diabetes. An association of dia-
betes with the concentration of lipid-adjusted total PCBs, PCB 153, PCB
functional group and TEQ DL-PCB serum levels was found by crude
analysis, but it disappeared when adjusting for age.
Accordingly, glycaemia increased with serum levels of total PCB, PCB
153, and immunotoxic, high-chlorinated and phenobarbital-inducing
PCBs, but again no association was found when multiple regression
analysis, including confounders, was performed. ANOVA models using
PCB distribution tertiles confirmed these findings. 
Several cross-sectional studies and cohort studies have evaluated the
association between serum concentration of PCBs and diabetes, gly-
caemia or insulin resistance so far. Some of them have been conducted
among people with high environmental exposure to PCBs or high intake
of contaminated food,27,28 but the majority of them included subjects with
low serum concentrations of PCBs.4,6,7,9,29-31 Many, 4,6-9,27,28,30-35 but not
all,5,10-14,36 studies found a statistically significant association between
PCB concentration and diabetes, glycaemia or insulin resistance. Two
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Table 3. Association between diabetes and tertiles of serum concentration of lipid-adjusted total polychlorinated biphenyls (PCBs), PCB
153, four PCB functional groups and total toxic equivalency dioxin like PCBs.
Lipid-adjusted PCB Presence of diabetes Prevalence Crude odds ratio Adjusted odds ratio*
concentration (ng/g lipid) No. of subjects/total (95% CI) (95% CI) (95% CI)
Total 53/527 10.0 (7.4-12.5)
Total PCBs
≤433.7 8/173 4.6 (1.4-7.7) 1 1
433.7-996.7 22/174 12.6 (7.6-17.5) 2.9 (1.3-6.9) 1.1 (0.4-3.0)
>996.7 23/180 12.8 (7.9-17.6) 3.0 (1.3-6.9) 0.7 (0.2-2.0)
PCB 153
≤135.8 8/173 4.6 (1.4-7.7) 1 1
135.8-282.0 19/174 10.9  (6.2-15.5) 2.5 (1.0-5.9) 1.1 (0.4-2.8)
>282.0 26/180 14.4 (9.2-19.5) 3.4 (1.5-7.9) 0.9 (0.3-2.4)
Immunotoxic PCBs 
(PCB138+153+180)
≤374.4 8/172 4.6 (1.4-7.7) 1 1
374.4-752.2 21/175 12.0 (7.1-16.8) 2.8 (1.2-6.5) 0.9 (0.3-2.6)
>752.2 24/180 13.3 (8.3-18.2) 3.1 (1.3-7.2) 0.7 (0.2-2.1)
Pseudo-oestrogen PCBs 
(PCB28+ 52+ 153)
≤135.8 8/173 4.6 (1.4-7.7) 1 1
135.8-282.0 19/174 10.9 (6.2-15.5) 2.5 (1.0-5.9) 1.0 (0.4-2.8)
>282.0 26/180 14.4 (9.2-19.5) 3.4 (1.5-7.9) 0.9 (0.3-2.4)
High chlorinated anti-oestrogenic PCBs 
(PCB170+180+194)
≤203.4 9/173 5.2 (1.8-8.5) 1 1 
2.03.4-488.9 24/174 13.8 (8.6-18.9) 2.9 (1.3-6.4) 1.0 (0.4-2.8)
>488.9 20/180 11.1 (6.5-15.6) 2.2 (1.0-5.1) 0.6 (0.2-1.8)
Phenobarbital inducer PCBs 
(PCB101+153+180+194)
≤309.2 8/173 4.6 (1.4-7.7) 1 1 
309.2-669.9 22/174 12.6 (7.6-17.5) 2.9 (1.3-6.9) 1.0 (0.4-2.7)
>669.9 23/180 12.8 (7.9-17.6) 3.0 (1.3-6.9) 0.7 (0.2-2.2)
TEQ DL-PCBs
≤0.03 12/228 5.2 (2.3-8.0) 1 1
0.03-0.09 15/98 15.3 (8.0-22.4) 3.2 (1.4-7.2) 1.2 (0.5-3.2)
>0.09 26/201 12.9 (8.2-17.5) 2.6 (1.3-5.4) 0.8 (0.3-1.9)
*Logistic regression models included age, gender, education and body mass index. CI, confidence interval; PBC, polychlorinated biphenyls; TEQ, total toxic equivalency.
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of them found a positive association among women, but not among
men,37,38 and one found a positive association for some PCB congeners
but not sum of PCBs.29 One study found PCB effects only at low doses,
suggesting a non-traditional dose-response relationship of POPs with
diabetes,30,32 although opposite results (associations only at the high-
est levels of PCB contaminations and dose-effect relationship) were
reported by many others.6,8,27,29,34 These findings are substantially in
agreement with those reported in a recent National Toxicology
Program Workshop Review, although it did not include the studies pub-
lished in 2011-12.39 Overall, these discrepancies does not seem to
depend on study area, study design, PCB serum levels, age and gender
of investigated people, and may be due to differences in exposure, in
terms of quantity and quality of PCBs investigated, and to not having
taking account of confounding factors and interaction. 
Various mechanisms to measure diabetogenic effect of dioxin and
PCB have been suggested.3,40,41 These chemicals exert their effects by
binding to the aryl-hydrocarbon receptor, which could promote diabeto-
genesis by antagonism of peroxisome proliferation-activated recep-
tors.41 Some authors, however, suggest that the effect of POPs may be
due to an interaction with the classic risk factors for diabetes, more
than to a direct causal relationship. Indeed, the NHANES survey con-
ducted on the U.S. general population found that obese people had a
higher frequency of insulin resistance than normal weight individuals,
but that the association between obesity and insulin resistance was
present only in people with high POP levels.8,42 Other authors have sug-
gested that PCB may act through increased inflammatory responses or
like steroid hormones,43 which may play a role in the development of
diabetes.44 However, an independent substantial role of POPs in caus-
ing diabetes at the commonly found environmental levels seems ques-
tionable to us, as the present worldwide diabetes epidemic has been
related universally to an increase in obesity, high calorie and high gly-
caemic load diets and physical inactivity, and various trials have clear-
ly shown that changes in diet and exercise can prevent diabetes effec-
tively, although they obviously cannot remove POPs from the body, as
noted by others.3
Serious environmental contamination of a PCB mixture was found
in the Brescia area, with a prevalence of hexa/hepta-chlorinated con-
geners and a minor component of lower chlorinated congeners and
dioxin-like congeners. PCDDs and PCDFs, but not TCDD, were also
found, although the DL-PCBs contributed to the overall toxicity equiva-
lent (TEQ) substantially, sometimes outweighing the contribution of
PCDD/Fs.17,18
This study has various strengths. First, it is a population-based study,
aiming to investigate PCB serum levels and the possible effects of this
exposure in a random sample of the general adult population living in
the town. Second, all the people included in the study were living in an
Article
Table 4. Geometric mean of glycaemia according to tertiles of lipid-adjusted polychlorinated biphenyls in 474 subjects without diabetes. 
Tertiles of lipid-adjusted Geometric mean One-way ANOVA on log-transformed data Multi-way ANOVA*
PCB concentration of glycaemia P values on log-transformed 
(ng/g lipid) data P values
Total 86.7
Total PCBs
≤433.7 84.2 0.0009 0.17
433.7-996.7 88.8
>996.7 88.0
PCB 153
≤135.8 84.3 0.001 0.75
135.8-282.0 88.0
>282.0 88.8
Immunotoxic PCBs 
(PCB138+153+180)
≤374.4 84.3 0.001 0.80
374.4-752.2 87.9
>752.2 88.8
Pseudo-oestrogen PCBs (PCB28+52+153)
≤135.8 84.3 0.001 0.75
135.8-282.0 88.0
>282.0 88.8
High chlorinated anti-oestrogenic PCBs 
(PCB170+180+194)
≤203.4 84.2 0.009 0.18
2.03.4-488.9 88.9
>488.9 87.2
Phenobarbital inducer PCBs (PCB101+153+180+194)
≤309.2 84.5 0.004 0.43
309.2-669.9 88.2
>669.9 88.3
TEQ DL-PCB
≤0.03 85.1 0.01 0.14
0.03-0.09 86.8
>0.09 89.3
*Fitted model included age, gender, education and body mass index. PBC, polychlorinated biphenyls; TEQ, total toxic equivalency
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industrialised town that has been highly polluted by PCBs, PCDDs and
PCDFs for many years. The high levels of PCBs still found in the soil in
some areas of the town (up to 8 mg/kg) suggest a persistent exposure
to PCBs for the whole population, long enough to allow an effect on gly-
caemia metabolism or diabetes to be detected. In fact, we found that
some of the people studied had very high serum PCB levels, with total
PCB lipid-adjusted values ranging up to 34377.8 ng/g lipid, 13 times
higher than the reference value for the adult population living in high-
ly industrialized areas in Italy (2650 ng/g lipid) and similar to those
found in other PCB-polluted areas,45 such as Anniston (USA) and
Michalovce (Slovakia).27,28 We also examined 24 PCB congeners,
including the most commonly implicated as endocrine disruptors, and
we collected information on serum lipid values and body mass index in
order to check for possible confounders. 
Furthermore, the presence of diabetes was confirmed in all cases
using the LHA database, including clinical data of high validity for each
subject. 
This study has some limitations as well. First of all, the relatively
small number of subjects with diabetes, which is not unexpected since
a random sample of the general adult population was included in the
study, most of whom were healthy. In our samples the diabetes percent-
age was 12.9% in males and 7.3% in females, in agreement with nation-
al data (10% in males and 7% in females).46
In conclusion, this cross-sectional and cohort study in a highly PCB-
polluted area does not support the hypothesis that environmental expo-
sure to PCBs and other POPs is associated with diabetes or glycaemia.
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